JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

Search

Omnicell Inc

Fechado

SetorSaúde

46.63 1.77

Visão Geral

Variação de preço das ações

24h

Atual

Mín

45.75

Máximo

49.7

Indicadores-chave

By Trading Economics

Rendimento

-177K

5.5M

Vendas

20M

311M

P/E

Médio do Setor

113.256

90.422

EPS

0.51

Margem de lucro

1.758

Funcionários

3,600

EBITDA

524K

31M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+18.28% upside

Dividendos

By Dow Jones

Próximos Ganhos

5 de fev. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

834M

2.2B

Abertura anterior

44.86

Fecho anterior

46.63

Sentimento de Notícias

By Acuity

50%

50%

152 / 352 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

Omnicell Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

3 de fev. de 2026, 23:11 UTC

Grandes Movimentos do Mercado
Aquisições, Fusões, Aquisições de Empresas

Silicon Laboratories Shares Up On Report of $7 Billion Texas Instruments Acquisition Deal

3 de fev. de 2026, 23:50 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

3 de fev. de 2026, 23:50 UTC

Conversa de Mercado

Nikkei May Decline After Hitting All-Time High -- Market Talk

3 de fev. de 2026, 23:42 UTC

Conversa de Mercado

Gold Edges Lower on Possible Technical Correction -- Market Talk

3 de fev. de 2026, 23:41 UTC

Aquisições, Fusões, Aquisições de Empresas

KKR Makes AI Play With $10.9B Asia Data-Center Deal

3 de fev. de 2026, 23:38 UTC

Ganhos

AMD Sales Climb on Help From Data-Center Business -- Update

3 de fev. de 2026, 23:29 UTC

Aquisições, Fusões, Aquisições de Empresas

KKR-Consortium Deal in STT GDC Is One of the Largest Digital-Infrastructure Transactions in Southeast Asia

3 de fev. de 2026, 23:27 UTC

Aquisições, Fusões, Aquisições de Empresas

Netflix, Warner Defend Proposed Deal in Senate Hearing -- WSJ

3 de fev. de 2026, 23:25 UTC

Aquisições, Fusões, Aquisições de Empresas

KKR-Consortium Expects Deal to Close by Early 2H of 2026

3 de fev. de 2026, 23:23 UTC

Aquisições, Fusões, Aquisições de Empresas

KKR Consortium With Singtel to Own 75% and 25% Stake in ST Telemedia Global Data Centres

3 de fev. de 2026, 23:22 UTC

Aquisições, Fusões, Aquisições de Empresas

KKR-Led Consortium to Buy Singapore-Based Global Data-Center Provider Valued at S$13.8B

3 de fev. de 2026, 23:19 UTC

Conversa de Mercado

Australia Gold Miners Tipped to Rally Higher -- Market Talk

3 de fev. de 2026, 23:19 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

3 de fev. de 2026, 22:56 UTC

Grandes Movimentos do Mercado
Aquisições, Fusões, Aquisições de Empresas

Silicon Laboratories Shares Up On Report of $7B Texas Instruments Acquisition Deal

3 de fev. de 2026, 22:40 UTC

Ganhos

Amdocs Extends Collaboration With T-Mobile

3 de fev. de 2026, 22:39 UTC

Ganhos

Amdocs 1Q Adj EPS $1.81

3 de fev. de 2026, 22:39 UTC

Ganhos

Amdocs 1Q Rev $1.16B

3 de fev. de 2026, 22:39 UTC

Ganhos

Amdocs 1Q EPS $1.45 >

3 de fev. de 2026, 22:38 UTC

Ganhos

Amdocs: Shimie Hortig to Succeed Shuky Sheffer as President and CEO, Effective March 31

3 de fev. de 2026, 22:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Bob Iger's Second Time as CEO Wasn't Great for the Stock. He Still Leaves Behind A Strong Legacy. -- Barrons.com

3 de fev. de 2026, 22:22 UTC

Aquisições, Fusões, Aquisições de Empresas

Texas Instruments Nearing $7B Deal for Silicon Laboratories, Sources Tell FT

3 de fev. de 2026, 22:14 UTC

Ganhos

AMD Expects to Scale AI Business to Tens of Billions in Annual Sales in 2027, CEO Says

3 de fev. de 2026, 22:13 UTC

Ganhos

AMD Expects Data-Center Unit Sales to Jump More Than 60% a Year Over Next Three to Five Years, CEO Says

3 de fev. de 2026, 22:12 UTC

Ganhos

AMD in Talks With Several Companies About At-Scale, Multi-Year Chip Deployments, CEO Says

3 de fev. de 2026, 22:10 UTC

Ganhos

AMD CEO: Eight of 10 Biggest AI Companies Use Instinct Chip to Power Production Workloads

3 de fev. de 2026, 22:10 UTC

Ganhos

Blackstone Stock, Alternative Managers, BDCs Dive as Software Woes Infect Private Credit -- Barrons.com

3 de fev. de 2026, 22:10 UTC

Conversa de Mercado

Key Drivers Underpinning Shaw's Bullish View of Gold Intact -- Market Talk

3 de fev. de 2026, 22:10 UTC

Ganhos

AMD CEO: Enterprises Are Modernizing Data Centers to Have Compute Needed for New AI Workflows

3 de fev. de 2026, 22:09 UTC

Ganhos

AMD CEO: Hyperscalers Expanding Infrastructure to Meet Growing Cloud-Services Demand in AI

3 de fev. de 2026, 22:09 UTC

Ganhos

AMD CEO: Demand Accelerated Across Data Center, Gaming and PC

Comparação entre Pares

Variação de preço

Omnicell Inc Previsão

Preço-alvo

By TipRanks

18.28% parte superior

Previsão para 12 meses

Média 57.6 USD  18.28%

Máximo 63 USD

Mínimo 52 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Omnicell Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

6 ratings

5

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

24.23 / 30.44Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

152 / 352 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat